Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...

The livestock monitoring market is expected to reach USD 2.57 billion by 2031 from USD 1.65 billion in 2025 at a CAGR of 7.7%, from 2025 to 2031 ...

The livestock identification market was valued at USD 1.74 billion in 2025 and is projected to reach USD 2.78 billion by 2031; it is expected ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...

the successful launch of WINREVAIR and strong performance of our Animal Health business," said Robert Davis, chairman and chief executive officer, Merck. Also Read: RJK Jr.'s Involvement In Merck ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.

Merck continues to showcase its award-winning “Show Type 2 Diabetes the Red Card” Campaign by providing complimentary screenings and health consultations to UAE residents at its booth with the support ...

Merck (MRK) stock was mangled today after the ... successful launch of WINREVAIR and strong performance of our Animal Health business.” Is MRK Stock a Buy, Sell, or Hold? Turning to Wall Street, ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.